General description
Deferoxamine is an iron chelating agent used in the treatment of iron overload, acute iron toxicity and in the management of sickle cell disease.
INN
Deferoxamine
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1979
(TRS
641)
for
Harmful effects of drugs, medicaments or biological substances, not elsewhere classified
Added in 2011
(TRS
965)
for
Other specified sickle cell disorders or other haemoglobinopathies
Added in 2023
(TRS
1049)
for
Thalassaemias
Wikipedia
DrugBank
Recommendations
Section
Antidotes and other substances used in poisonings > Specific
- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)
Section
Other medicines for haemoglobinopathies
- Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)